Effects of glucose on circulating and ileal intraluminal peptide YY and pancreatic polypeptide release.
Peptide YY (PYY) and pancreatic polypeptide (PP) are related hormones released systemically after a meal. The effects of glucose stimulation and vagal involvement on circulating and ileal luminal PYY and PP concentrations were evaluated in awake dogs. An oral glucose tolerance test (OGTT), intravenous glucose tolerance test (IVGT), 2-deoxyglucose bolus (2-DG), or atropine pretreatment prior to OGTT were administered to awake dogs with 25-cm ileal Thiry-Vella fistulas. Circulating and ileal intraluminal PYY and PP levels were measured by radioimmunoassay. No changes were noted in circulating PYY, and circulating PP increased (p less than 0.05) only after administration of 2-DG. Ileal luminal PP recovery was minimal (less than 60 pg/mL) and was unchanged after all tests. Ileal luminal PYY recovery increased significantly after both OGTT and IVGT. Pretreatment with atropine abolished the luminal PYY response to OGTT, and 2-DG did not affect luminal PYY recovery. Blood glucose and insulin levels were similar in all groups. Peripheral cholinergic control of luminal PYY release is suggested by our findings, whereas a central mediation of circulatory PP release is supported by 2-DG stimulation.
Department of Surgery, University of Cincinnati School of Medicine, Ohio 45267.
M
M
Rudnicki
D W
DW
McFadden
B W
BW
Kuvshinoff
R
R
Dayal
J E
JE
Fischer
D000818:Animals; D004285:Dogs; D005768:Gastrointestinal Hormones / Q000097:blood / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology*; D005951:Glucose Tolerance Test; D007082:Ileum / Q000378:metabolism; D007413:Intestinal Mucosa / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000097:blood / Q000378:metabolism*; D019894:Peptide YY; D010455:Peptides / Q000097:blood / Q000378:metabolism*; D011863:Radioimmunoassay
D005768:Gastrointestinal Hormones; D010455:Peptides; D019894:Peptide YY; D010191:Pancreatic Polypeptide; D005947:Glucose